The CRF system, stress, depression and anxiety-insights from human genetic studies

被引:270
作者
Binder, E. B. [1 ,2 ,3 ]
Nemeroff, C. B. [4 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
[2] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Munich, Germany
[3] Emory Univ, Sch Med, Dept Human Genet, Munich, Germany
[4] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
关键词
CRF; CRH; receptor; genetic; depression; anxiety; CORTICOTROPIN-RELEASING-FACTOR; GENOME-WIDE ASSOCIATION; CEREBROSPINAL-FLUID CONCENTRATIONS; MESSENGER-RNA EXPRESSION; NUCLEOTIDE POLYMORPHISM ANALYSIS; 17Q21.31 MICRODELETION SYNDROME; FACTOR-LIKE IMMUNOREACTIVITY; HEALTHY CONTROL SUBJECTS; HORMONE-BINDING PROTEIN; MAJOR DEPRESSION;
D O I
10.1038/mp.2009.141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A concatenation of findings from preclinical and clinical studies support a preeminent function for the corticotropin-releasing factor (CRF) system in mediating the physiological response to external stressors and in the pathophysiology of anxiety and depression. Recently, human genetic studies have provided considerable support to several long-standing hypotheses of mood and anxiety disorders, including the CRF hypothesis. These data, reviewed in this report, are congruent with the hypothesis that this system is of paramount importance in mediating stress-related psychopathology. More specifically, variants in the gene encoding the CRF1 receptor interact with adverse environmental factors to predict risk for stress-related psychiatric disorders. In-depth characterization of these variants will likely be important in furthering our understanding of the long-term consequences of adverse experience. Molecular Psychiatry (2010) 15, 574-588; doi: 10.1038/mp.2009.141; published online 15 December 2009
引用
收藏
页码:574 / 588
页数:15
相关论文
共 190 条
  • [1] Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence
    Adinoff, B
    Anton, R
    Linnoila, M
    Guidotti, A
    Nemeroff, CB
    Bissette, G
    [J]. NEUROPSYCHOPHARMACOLOGY, 1996, 15 (03) : 288 - 295
  • [2] ELEVATED CSF CRF IN SUICIDE VICTIMS
    ARATO, M
    BANKI, CM
    BISSETTE, G
    NEMEROFF, CB
    [J]. BIOLOGICAL PSYCHIATRY, 1989, 25 (03) : 355 - 359
  • [3] The role of corticotropin-releasing factor in depression and anxiety disorders
    Arborelius, L
    Owens, MJ
    Plotsky, PM
    Nemeroff, CB
    [J]. JOURNAL OF ENDOCRINOLOGY, 1999, 160 (01) : 1 - 12
  • [4] Human CRF2 α and β splice variants:: pharmacological characterization using radioligand binding and a luciferase gene expression assay
    Ardati, A
    Goetschy, V
    Gottowick, J
    Henriot, S
    Valdenaire, O
    Deuschle, U
    Kilpatrick, GJ
    [J]. NEUROPHARMACOLOGY, 1999, 38 (03) : 441 - 448
  • [5] Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men
    Austin, MC
    Janosky, JE
    Murphy, HA
    [J]. MOLECULAR PSYCHIATRY, 2003, 8 (03) : 324 - 332
  • [6] Distribution of corticotropin-releasing hormone promoter polymorphism in different ethnic groups: evidence for natural selection in human populations
    Baerwald, CGO
    Mok, CC
    Fife, MS
    Tikly, M
    Lau, CS
    Wordsworth, BP
    Ollier, B
    Panayi, GS
    Lanchbury, JS
    [J]. IMMUNOGENETICS, 1999, 49 (10) : 894 - 899
  • [7] Baerwald CGO, 1996, HUM GENET, V97, P697
  • [8] Baker DG, 1999, AM J PSYCHIAT, V156, P585
  • [9] Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
    Bale, TL
    Contarino, AB
    Smith, GW
    Chan, R
    Gold, LH
    Sawchenko, PE
    Koob, GF
    Vale, WW
    Lee, KF
    [J]. NATURE GENETICS, 2000, 24 (04) : 410 - 414
  • [10] Banki C M, 1992, Eur Neuropsychopharmacol, V2, P107, DOI 10.1016/0924-977X(92)90019-5